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Abstract
Colorectal tumors mostly arise from sporadic adenomatous polyps. Polyps are defined as a mass of cells that pro-
trudes into the lumen of the colon. Adenomatous polyps are benign neoplasms that, by definition display some
characteristics of dysplasia. It has been shown that polyps were benign tumors which may undergo malignant
transformation. Adenomatous polyps have been classified into three histologic types; tubular, tubulovillous, and vil-
lous with increasing malignant potential. The ability to differentially diagnose these colorectal adenomatous polyps
is important for therapeutic intervention. To date, little efforts have been directed to identifying genetic changes
involved in adenomatous polyps. This study was designed to examine the relevance of mitochondrial genome
alterations in the three adenomatous polyps. Using high resolution restriction endonucleases and PCR-based
sequencing, fifty-seven primary fresh frozen tissues of adenomatous polyps (37 tumors and 20 matched surround-
ing normal tissues) obtained from the southern regional Cooperative Human Tissue Network (CHTN) and Grady
Memorial Hospital at Atlanta were screened with three mtDNA regional primer pairs that spanned 5.9 kbp. Results
from our data analyses revealed the presence of forty-four variants in some of these mitochondrial genes that the
primers spanned; COX I, II, III, ATP 6, 8, CYT b, ND 5, 6 and tRNAs. Based on the MITODAT database as a sequence
reference, 25 of the 44 (57%) variants observed were unreported. Notably, a heteroplasmic variant C8515G/T in the
MT-ATP 8 gene and a germline variant 8327delA in the tRNA
lys was observed in all the tissue samples of the three
adenomatous polyps in comparison to the referenced database sequence. A germline variant G9055A in the MT-
ATP 6 gene had a frequency of 100% (17/17) in tubular and 57% (13/23) in villous adenomas; no corresponding
variant was in tubulovillous adenomas. Furthermore, A9006G variant at MT-ATP 6 gene was observed at frequency
of 57% (13/23) in villous adenomas only. Interestingly, variants A9006G and G9055A were absent in the villous tis-
sue samples that were clinicopathological designated as “polyvillous adenomas”. Our current data provide a basis
for continued investigation of certain mtDNA variants as predictors of the three adenomatous polyps in a larger
number of clinicopathological specimens.
Findings
Adenomatous polyps are histologically divided into tub-
ular adenomas, villous adenomas, and mixed or tubulo-
villous adenomas [1,2]. There is considerable clinico-
pathological evidence that support adenomatous polyp
to be a precursor lesion in most of colorectal cancers.
Colorectal malignancy risk correlate with the transfor-
mation of a polyp from low risk tubular adenomas to
high pure villous adenomas, while the tubulo-villous
have an intermediate risk of malignant transformation
[2]. At molecular level, changes from tubular to villous
through tubulo-villous adenomas may be due to accu-
mulation in mutations of oncogenes, tumor suppressor
genes [3-5] and mitochondrial DNA variants within a
specific cell and haplogroups [6-8]. These mutations
may be adenomatous polyp specific and could poten-
tially be employed as polyp predictors. It is not known,
however, whether these mutations are needed to initiate
and/or promote tumorigenesis or whether they result
from the genomic instability inherent in the resulting
colorectal adenocarcinoma [7]. This study examined the
possibility of using mitochondrial DNA variants to dif-
ferentiate the three adenomatous polyps of colon and
their matched surrounding paracancerous normal tis-
sues. The mitochondrial genome is particularly suscepti-
ble to mutation because of its high local level of reactive
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cause subtle changes in the protein subunits comprising
the complexes involved in mitochondrial oxidative phos-
phorylation (OXPHOS) activity and lead to even higher
levels of ROS [11] (ROS are a by product of normal
OXPHOS). The accumulation of ROS and oxidative
DNA damage during the course of a lifetime may be
deleterious and could lead to specific mitochondrial
genome markers that may be involved in the develop-
ment and progression of colorectal cancer [7,12], since
colorectal cancer usually occurred in older individuals.
In addition, mutant mtDNA may also play a role in
tumorigenesis because mutant mitochondria may adapt
a replicative advantage, such as deletions/insertions,
leading to abnormal cell growth and, ultimately could
lead to colorectal adenocarcinoma [13,14].
This study was approved by the Institutional Review
Board of Morehouse School of Medicine, the Research
Oversite Committee of the Grady Memorial Hospital,
A t l a n t a ,G e o r g i aa n dt h eU n i v e r s i t yo fA l a b a m aa tB i r -
mingham School of Medicine, Birmingham, Alabama.
Fifty-seven primary fresh frozen tissues from 3 histolo-
gic adenomatous polyps and some of their matched sur-
rounding paracancerous normal tissues (12 tubular and
5 matched surrounding tissues; 11 tubulovillous and 6
matched surrounding tissues; and 14 villous and 9 sur-
rounding tissues; a subset of 10 out of 23 villous ade-
noma samples were designated as ‘polyvillous adenomas’
(6 polyvillous and 4 matched surrounding tissues) used
in this study were obtained from southern regional
Cooperative Human Tissue Network (CHTN) at the
University of Alabama, Birmingham, Alabama and the
Grady Memorial Hospital, Atlanta, Georgia. Based on
the availability of tissue samples not all the 3 adenoma-
tous polyps were matched with surrounding paracancer-
ous normal tissues were analyzed. Colorectal
adenomatous polyps were classified as tubular, tubulo-
villus, and villous based on the defined histologic type,
degree of dysplasia, and presence of infiltrating adeno-
carcinoma in adenoma. Diagnosis was confirmed by his-
tological examinations of biospied specimens for all
patients and pathological tumor staging for these was
based on American Joint Committee on Cancer. The
mean age of the study patients where tissue samples
were obtained was 68.3 ± 5.5 years.
To increase the quality of target DNA obtained from
small samples, laser-capture microdissection was per-
formed on the tissue samples with the used of an Arctus
PixCell II microscope (Arcturus Engineering) for repli-
cation of the distance between the polyps and matched
surrounding paracancerous normal-appearing cells.
MtDNA was extracted from primary frozen tissue sam-
ples using centrifugation method according to the man-
ufacturer’s protocols (BioVision, Research Products).
The extracted mtDNA from 37 adenomatous polyps
and 20 matched surrounding paracancerous normal tis-
sues were quantified, and diluted to 50 ng/μlf o rP C R
reaction using three mtDNA regional primer pairs.
These primer sets spanned 7392 to 8902 (sense 5’-
GGATGCCCCCCACCCTACC-3’,a n t i s e n s e5 ’-
CCTTGTGGTAAGAAGTGGGC-3’; 1530 bp) 8282 to
10088 (sense 5’-CCCCTCTAGAGCCCACTGTAAAGC-
3’,a n t i s e n s e5 ’-GTAGTAAGGCTAGGAGGGTG-3’;
1826 bp) and 13914 to 16527 (sense 5’-CGGATTC-
TACCCTAGCA-3’,a n t i s e n s e5 ’-GGAACGTGTGGGC-
TATTTAGG-3’; 2634 bp) including these mitochondrial
genes; COX I, II, III ATPase 6, 8, CYT b ND 5, 6 and
tRNAs as previously described [6,7]. These resulted in
large amplicons that exclude the possibility of amplify-
ing nuclear pseudogenes. MtDNA variants were
detected by high resolution restriction digestions and
PCR based sequence as previously described [7,12].
Sequences of sense and anti-sense strands were derived
with 3100 Genetic Analyzer. Sequences were aligned
and compared to human mtDNA [GenBank: J01415]
and within samples sequence comparison were made in
relationship to the three colorectal adenomatous polyps
and the matched normal tissues. For comparison pur-
poses, samples from the general population (n = 50) for
which mtDNA was amplified and sequenced using lym-
phocytes as a surrogates tissues were also used in
sequence alignment. MtDNA sequence variants present
in both the tumor and matched normal tissue were
scored as germ-line variants. Any mtDNA sequence var-
iant that was different between the tumor and the
matched normal tissues were scored as somatic muta-
tions. The MITODAT database was used to determine
previously published sequences.
Comparison of sequences of mitochondrial DNA
obtained from 57 different primary colorectal adenoma-
tous polyps (37 adenomatous polyps cases and 20
matched surrounding paracancerous normal tissues)
with the MITODAT database [#J01415] reference
revealed 44 sequence variants, in parts of these mito-
chondrial genes; ATP 6, 8, CYT b and ND 5, 6 and
tRNAs. Nineteen of 44 (43%) variants were previously
reported, 25 of 44 (57%) were unreported variants. We
found 4 somatic mutations when adenomatous polyps
mtDNA variants were compared with matched sur-
rounding paracancerous normal mtDNA variants. The
somatic mutations were observed amongst the matched
surrounding paracancerous normal tissues of polyvillous
adenomas samples only, a designated subset of villous
adenoma. The loci of nucleotide variants amongst color-
ectal adenomatous polyp samples appear to be consis-
tent. The following deletions 8327delA, 13945delA,
13946delT, 14652delA, 14715delA were detected in
tRNA
lys, ND 5, 6,a n dt R N A
glu,w h i c hw e r em o s t l y
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Page 2 of 6found in tubular adenoma (Table 1). These observed
slippage mutations (frameshifts) within the mtDNA cod-
ing regions might be a reflection of selective constrains
and perhaps account for the progression of colorectal
adenomatous polyps to adenocarcinoma. Notably, a het-
eroplasmic variant C8515G/T in the MT-ATP 8 gene
and a germline variant 8327delA in the tRNA
lys was
observed in all the tissue samples of the three adenoma-
tous polyps in comparison to the referenced database
sequence. A germline variant G9055A in the MT-ATP 6
gene had a frequency of 100% (17/17) in tubular and
57% (13/23) villous adenomas; no corresponding variant
was in tubulovillous adenomas.
Furthermore, A9006G variant at MT-ATP 6g e n ew a s
also observed at frequency of 57% (13/23) in villous ade-
nomas only (Table 1, Figure 1). Interestingly, variants
A9006G and G9055A were absent in the villous tissue
samples that were clinicopathological designated as
“polyvillous adenomas”. Past study suggested that var-
iants in the mtDNA ATP synthase subunit 6 gene seems
to contribute positively to the promotion of cancer by
prevention of apoptosis [15,16]. A high frequency of 70-
85% variants were observed in ND subunits 5, 6 and
CYT B genes (Table 1). The disparate mutational spec-
tra found among the three colorectal adenomatous
polyps and the matched surrounding paracancerous nor-
mal tissues may reflect difference in underlying colorec-
tal tumor biology as the disease progress as previously
described in paragangliomas tumor [17].
Moreover, variants A14633G and 14652delA in the
MT-ND6 gene was found only in the polyvillous adeno-
mas, a designated subset of villous adenomas (Table 1).
The difference in mtDNA variants in the ND gene
between villous and the polyvillous adenomas is particu-
larly striking because it may indicate that polyvillous ade-
nomas is a polyp of invasive carcinoma with high amount
of reactive oxygen species. A recent study based on
mouse tumor cell line with the application of cytoplasmic
hybrid techniques suggested that the main effect of MT-
ND 6 gene mutations were the defect in the respiratory
complex I activity that lead to overproduction of reactive
oxygen species. Additionally, this study also reported that
mutations in the ND 6 region affected the metastatic
potential of the tumor cells and had no effect on the can-
cer development [15]. Based on the observed mtDNA
variants between the villous adenoma and the polyvillous
adenoma in this study, the polyvillous adenomas may be
considered to be an invasive villous adenocarcinoma.
Given that most of the villous adenoma in our samples
were large endoscopically unresectable tumors that went
to surgical resection even if they were not diagnosed as
carcinoma on biopsy as previously described [18]. A
study has described two similar colon tumors with the
designation of invasive papillary adenocarcinoma and
s u g g e s t e dt h a tt h e s et u m o r sm a yh a v eam o r ea g g r e s s i v e
course than typical colonic adenocarcinoma [19]. Inter-
estingly, Loy and Kaplan [18] used the presence of the
epithelial island in desmoplastic stroma to histological
distinguish cases of villous adenocarcinoma and villous/
tubulovillous adenomas and emphasize the tumor’s
malignant of villous adenocarcinomas and it’s morpholo-
gic similarities to villous adenomas.
In this study, we have observed that, in regard to
mtDNA from the 3 colorectal adenomatous polyps,
there is an appreciable difference in the frequency of
sequence variants that potentially distinguished the tub-
ular, tubulovillous and villous adenomas. Also, these
finding shows that there are difference in mtDNA var-
iants between villous adenomas and the designated poly-
villous adenomas, and mitochondria may be involved in
the process of colorectal adenomatous polyps. Based on
this study and others, we suggest that classifying polyvil-
lous adenomas as distinct subset of villous adenomas
will allow further study of the diagnostically challenging
colorectal adenomatous polyps. Perhaps, the designated
polyvillous adenomas may be termed as villous adeno-
carcinoma to emphasize this tumor’s malignant poten-
tial, morphologic similarities to villous adenomas [18]
with genetic differences. However, whether these
mtDNA variants identified influence the functionality of
the mitochondrial in the colorectal cells during malig-
nancy of the villous adenocarcinoma is a matter that
needs to be investigated. Larger, population-based stu-
dies are required to quantify the functional role of
mtDNA sequence variants in histological colorectal ade-
nomatous polyps and that may subsequently enhance
classification of these early colorectal tumors and may
facilitate the development of diagnostic adjuncts and an
appropriate therapeutic choice. Since we sequenced only
a 5.9 kb fragment of the 16.5 kb mitochondrial genome,
the number of mtDNA sequence variants that could
correlate with the 3 colorectal adenomatous polyps may
exceed the number we observed.
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Page 3 of 6Table 1 Frequency of mtDNA variants among colorectal adenomatous polyps
MT GENES/
REGION
MTDNA VARIANTS % FREQUENCY ADENOMATOUS POLYPS NOTES
Tubular Tubulovillous Villous
MT-ATP6 A9006G - - 57 * R
MT-ATP6 G9055A 100 - 57 * NR
MT-ATP6 A9093G 100 - R
MT-ATP6 A8860G 100 100 100 R
MT-ATP6 A9169C 75 NR
MT-ATP8 C8515G/T 100 100 100 R
MT-ATP8 G8697A 43** R
MT-tRNA 8327 del A 100 100 100 R
MT-ATP6 G8864T 17*** R
a
MT-ATP6 G8865A 17*** R
MT-ATP6 A8340G 17*** R
MT-ATP6 T8363C 17*** R
b
MT-ATP 6 G8994A 85 NR
MT-ATP6 G8696A 20 43** NR
MT-ATP6 A8701G 25 R
MT-ND5 C13938G 85 NR
MT-ND5 C13939G 85 NR
MT-ND5 G13940T 85 NR
MT-ND5 C13941A 85 R
c
MT-ND5 A13942G 85 R
MT-ND5 C13943A 85 R
d
MT-ND5 13945 delA 75 NR
MT-ND5 13946 delT 85 NR
MT-ND5 C13947G 85 NR
MT-ND5 C13949T 85 NR
MT-ND5 C13960A 70 NR
MT-ND5 A13969C 70 NR
MT-ND5 A13973T 80 NR
MT-ND5 A13974T 80 NR
MT-ND5 A13975G 80 NR
MT-ND5 A13976G 80 NR
MT-ND5 C13977G 80 NR
MT-ND5 C13978G 80 NR
MT-ND5 T13979G 80 NR
MT-ND5 A13995T 80 NR
MT-ND5 G13996T 80 NR
MT-ND5 A14002G 57 * R
MT-ND5 G14040A 57 * R
MT-ND5 C14167T 75 57 * R
MT-ND6 T14180C 70 R
MT-ND6 A14233G 43 ** R
MT-ND6 14652del A 43 ** NR
M-tRNA 14715del A 80 43 ** NR
MT-CYTB A14782T 90 NR
* Germ-line mutations/polymorphisms found in all our studied villous adenomas tissues samples only, but not in tissue samples designated as polyvillous
adenaomas.
**Germ-lines mutations/polymorphisms found in all our studied tissue samples designated as polyvillous adenomas only, but not in villous adenomas tissues
samples.
*** Somatic mutations found in matched surrounding paracancerous normal tissues of polyvillous adenomas in our studied tissue samples only.
R Mutations/polymorphisms are previously reported.
NR Mutations/polymorphisms are unreported.
R
a Mutation previously reported as G8864A; R
b Mutation previously reported as A8363T.
R
c Mutation previously reported as C13941G; R
d Mutation previously reported as C13943T.
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